CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 122 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06978218
NCT06978218N/ACompleted

Cognitive Changes in Menopause: A Comparative Analysis of Brain Fog and Quality of Life

Merve Coskun·observational·Posted May 18, 2025·Updated Aug 11, 2025

In Brief

An observational study for Menopause and 6 related conditions. Completed, enrolled 122 participants across 1 site.

Detailed Summary

This clinical study aims to investigate cognitive changes in women undergoing the menopausal transition, with a specific focus on the prevalence, characteristics, and impact of brain fog. The research will assess how declining estrogen levels influence cognitive domains such as memory, attention, and executive function across different menopausal stages (perimenopause, menopause, and postmenopause). Through a comparative and observational design, the study will evaluate the relationship between subjective cognitive complaints and menopause-specific quality of life. Findings are expected to inform the development of non-pharmacological strategies-such as lifestyle modifications and cognitive health interventions-to mitigate cognitive decline and improve overall well-being in midlife women.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
2026
First PostedMay 18, 2025
Enrollment StartMay 8, 2025
Primary CompletionJul 16, 2025
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 1.1 years ago